The Syndesi Therapeutics drug is directly targeting dementia, the core symptom of Alzheimer’s disease. Photograph:  John Stillwell/PA

Irish venture capital group Fountain Healthcare has invested in a Belgian start-up that is investigating a dementia therapy. The company, Syndesi The(...)